While reagent limitations restrained the detection of APE1 in post-mortem brain by immunohistochemistry [153], the APE1 mRNA level is decreased in entorhinal cortex in AD brains compared to controls (Figure 4) [154]. This evidence concerns the gene APEX1 and Alzheimer disease.